Found 70 matching trials
PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment NA Pilot Immunotherapy Study of Combination Prostate Specific Membrane Antigen...
Show More Location
H. Lee Moffitt Cancer Center & Research Institute
Learn More & Join Trial
Gene-Modified Immune Cells (FH-MCVA2TCR) in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer PHASE1 This phase I/II trial studies the side effects of gene-modified immune cell...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
Vaccine Therapy in Treating HLA-A2 Positive Patients With Melanoma PHASE2 This randomized pilot phase II trial studies how well vaccine therapy works...
Show More Location
Providence Portland Medical Center
Learn More & Join Trial
A Pilot Study of Glioma Associated Antigen Vaccines in Conjunction with Poly-ICLC in Pediatric Gliomas PHASE1 The overall objective of this pilot study is to collect immunological and s...
Show More Location
Children's Hospital of Pittsburgh of UPMC
Learn More & Join Trial
Vaccine Therapy in Treating Patients With Transitional Cell Carcinomas PHASE1 RATIONALE: Vaccines made from peptides may make the body build an immune re...
Show More Location
Memorial Sloan-Kettering Cancer Center
Learn More & Join Trial
Two Step Haplo With Radiation Conditioning PHASE2 This phase II clinical trial evaluates whether a modified modality of condi...
Show More Location
Sidney Kimmel Cancer Center at Thomas Jefferson University
Learn More & Join Trial
H3.3K27M Peptide Vaccine With Nivolumab for Children With Newly Diagnosed DIPG and Other Gliomas PHASE1 This is 3-arm, multicenter study that will be conducted through the Pacific...
Show More Location
Rady Children's Hospital-San Diego
Learn More & Join Trial
A Phase I Safety Study of a Cancer Vaccine to Treat HLA-A2 Positive Advanced Stage Ovarian, Breast and Prostate Cancer PHASE1 To determine the safety and immunogenicity profile of two (2) different dos...
Show More Location
Rush University Medical Center
Learn More & Join Trial
Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas EARLY_PHASE1 This is a pilot vaccine study in adults with either WHO grade II astrocytom...
Show More Location
Comprehensive Cancer Center of Wake Forest University
Learn More & Join Trial
Safety and Efficacy Study of GL-0817 (With Cyclophosphamide) for the Prevention of Recurrence of Squamous Cell Carcinoma of the Oral Cavity PHASE2 This is a multi-center, randomized, double-blind clinical trial to assess t...
Show More Location
University of Maryland Greenebaum Cancer Center
Learn More & Join Trial